Amgen Inc.

NAS : AMGN
Pharmaceuticals
Thousand Oaks CA
2013 Revenue (US$ Millions)$18,676
2012 Revenue (US$ Millions)$17,265
Revenue Growth (%)8.17%
Net Income (US$ Millions)$5,081
Common Shares Outstanding (Millions)$755
Earnings Per Share (US$)$6.64
Price To Earnings Ratio118.69
Total Equity (US$ Millions)$22,096
Profit Margin (%)27.21%
Return On Equity (%)26.66%
Long Term Debt (US$ Millions)$29,623
Debt To Equity Ratio (%)1.34%
Market Capitalization (US$ Millions)$86,085
Total Assets (US$ Millions)$66,125
Return on Assets (%)9.36
Current Assets (US$ Millions)$27,367
Inventories (US$ Millions)$3,019
Current Liabilities (US$ Millions)$7,947
Cost of Goods Sold (US$ Millions)$3,346
Asset Turnover0.28
Inventory Turnover1.16
ExchangeNAS